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herapy Response
Physiologic Approach
o Dyssynchrony Therapy*
homas H. Marwick, MBBS, PHD, FACC,†
andall C. Starling, MD, MPH, FACC‡
risbane, Australia; and Cleveland, Ohio
ecently published studies have emphasized the technical
ifficulty of assessing mechanical left ventricular (LV) syn-
hrony in patients undergoing cardiac resynchronization
herapy (CRT). The failure of a large, multicenter study to
dentify benefit from CRT in dyssynchronous, narrow
omplex heart failure (1), as well as the failure of synchrony
arkers to predict success of CRT (2), has cast a cloud over
he utility of assessment of mechanical synchrony.
See page 1402
The study reported by Ypenburg et al. (3) in this issue of
he Journal should go some way towards balancing the
ecent negative reports of mechanical assessment of syn-
hrony. These investigators related the results of speckle
racking radial strain and LV lead position on chest X-ray in
44 CRT candidates, and followed them sequentially with:
) an echocardiogram at 6 months; and 2) long-term clinical
ollow-up. Concordance between the site of maximal delay
nd lead position was obtained in 63% of patients, who
emonstrated significant reverse remodeling, in contrast to
atients with discordance between the site of maximal delay
nd lead position, who showed no significant changes in LV
olume.
Moreover, the combination of death and heart failure
ospitalization over the ensuing 32 months was less in the
atients with concordant lead position, with a hazard ratio
f 0.22. Importantly, although the groups with concordant
Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.
From the †University of Queensland, Brisbane, Australia; and the ‡Cleveland
linic, Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio. This program
s supported, in part, by a Clinical Centre of Research Excellence award from thea
ational Health and Medical Research Council of Australia. Dr. Starling is a
onsultant for Medtronic (annual sum $10,000).nd discordant lead position differed in other ways (e.g.,
schemic etiology and QRS duration), multivariate analysis
onfirmed the relationship of maximal delay to lead position
o be independently related to outcome.
This is an important observation that adds further insight
nto the mechanism of effective CRT. There are conflicting
eliefs regarding the importance of mechanical synchrony to
RT response. One is based on the outcomes evidence
btained from the CARE-HF (Cardiac Resynchronization
eart Failure) and COMPANION (Comparison of Med-
cal Therapy, Resynchronization, and Defibrillation Thera-
ies in Heart Failure) studies (4,5), which show that device
herapy is effective across populations defined on the basis of
lectrical dyssynchrony. As mechanical synchrony had only
minor role in the selection of patients for the CARE-HF
tudy, proponents of this viewpoint emphasize the efficacy
f device therapy across this group, and support the princi-
le of implanting devices irrespective of the evidence (or
ack thereof) of mechanical dyssynchrony.
Another school of thought has a more physiologic ap-
roach to CRT therapy. The proponents of this viewpoint
ontend that the mechanism of effect of CRT is mechanical
esynchronization of the ventricle, allowing more efficient,
niform contraction, and they anticipate that it is this effect
hat is responsible for the improvement of LV function,
unctional class, and survival. Studies have demonstrated
hat the degree of dyssynchrony changes with CRT corre-
ates with the improvement of LV volume (although not
cross the whole spectrum of synchrony improvement) (6).
ndeed, a correlation has been demonstrated between the
egree of improvement of dyssynchrony, cardiac remodel-
ng, and functional outcome (7).
Figure 1 emphasizes the relationship of electrical and
echanical synchrony and their implications for CRT
esponse. In the middle are a group of patients with both
echanical dyssynchrony and electrical dyssynchrony due to
onduction disease—these patients usually present with a
ide QRS (150 ms) and a normal-sized but dyssynchro-
ous LV with reduced ejection fraction. Patients in this
roup are typically dramatic responders, as long as CRT is
roperly deployed (i.e., in the posterolateral wall). A related
roup has both mechanical dyssynchrony and electrical
yssynchrony due to myocardial disease or ischemia. These
atients have a wide QRS (150 ms) and a large and
yssynchronous LV with reduced ejection fraction, who can
e expected to respond to CRT if the myocardium is viable
nd the pacing site corresponds to the site of maximum
elay. Next, there is a group of patients with significant
echanical dyssynchrony but without profound electrical
yssynchrony (narrow QRS). Such patients (often described
s having “narrow QRS”) would probably respond if mechan-
cal dyssynchrony could be reliably identified and leads were
laced in the optimal position. The last group—and perhaps
he most important patient population in which CRT could be
voided if evidence was gathered with an appropriate marker of
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ut without mechanical dyssynchrony.
Most patients with a wide QRS have a subjective clinical
esponse, as mechanical dyssynchrony is often associated
ith electrical dyssynchrony; this explains why LV mechan-
cal dyssynchrony predicts outcome with CRT (6,7). This
oncept also explains why the large outcomes trials have
hown a relationship between QRS duration and CRT
enefit (4,5). This CRT benefit is explained by “being in the
ight place (lateral wall) at the right time” (reducing the
ight ventricular/LV interventricular conduction delay). Un-
ortunately, the identification of mechanical dyssynchrony
mechanism) and proper lead location (place) are required to
chieve the optimum achievable in any given patient. Some
atients, however, just do not have the proper anatomy to
chieve the ideal place (venous anatomy), and some have just
oo much scar tissue and not enough recruitable myocardium.
The investigations that have correlated the site of maxi-
al dyssynchrony and the pacing site have offered a fresh
ngle in this argument. This investigation follows several
revious reports (Table 1), which have emphasized the
enefits of lead localization in the site of latest activation
8–13). These studies have shown that the closer that
acing is performed to the site of maximal dyssynchrony,
he greater benefit to the patient, at least in terms of cardiac
unction. This landmark study moves this observation to the
Figure 1 A Spectrum of Electrical and Mechanical Dyssynchron
Interrelationship of electrical and mechanical dyssynchrony is indicated by the ove
alone require further validation to determine if they derive benefit from cardiac resext level, by demonstrating that correlation between pacing vite and site of maximal dyssynchrony translates into better
linical outcomes proven with hard end points (mortality
nd heart failure hospitalizations). It should also be empha-
ized that these incremental clinical benefits were achieved
fter evidence-based medical therapies were optimized.
The findings of this report support the importance of
estoring synchrony as the mechanism of effect of CRT. They
upport the hypothesis that the failings of recent trials relate to
ther matters than a lack of importance of mechanical syn-
hrony. LV leads are implanted in an anterior or anterolateral
ein in 30% of cases (14), despite evidence that long-term
emodynamic and neurohormonal benefit depends on lead
osition (15). Of course, there are also shortcomings of current
echniques used for the assessment of mechanical synchrony,
nd, indeed, these limitations justify the failure to include
echanical synchrony in most, but not all, guidelines. None-
heless, the findings of the study of Ypenburg et al. (3) should
ncourage us in the ongoing search for an optimal marker of
ynchrony that can be used in patient selection to help solve the
iddle of CRT response. Indeed, the stakes in this are high—
ssuming that only 10% of implants are inappropriate (a
onservative estimate), the potential savings in the U.S. alone
ould be over $2 billion. The increase in prevalence of heart
ailure and the expense of this modality certainly justify the
eed for a sequence of careful investigations that will evaluate
yocardial viability, the site of maximal dyssynchrony, and the
ists for Most Patients and Often Both Are Interrelated
atients with either electrical or mechanical dyssynchrony
nization therapy (CRT). RCT  randomized controlled trial.y Ex
rlap. P
ynchroenous anatomy, to ensure that patients who have a device
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Echocardiography and CRT Selection October 21, 2008:1410–2mplanted are likely to enjoy a clinical and physiologic re-
ponse. The continued avoidance of mechanical dyssynchrony
n favor of QRS duration alone to identify candidates for CRT
herapy will propagate the pool of CRT recipients that are
nonresponders.”
eprint requests and correspondence: Dr. Thomas H. Marwick,
niversity of Queensland, Department of Medicine, Princess
lexandra Hospital, Ipswich Road, Brisbane, Qld 4102, Australia.
-mail: t.marwick@uq.edu.au.
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58 47 47
12 10 3
3DE 2DS 2DS
32 ml 42 ml 9%
21 ml 27 ml 5%
0.01 0.001 0.001
10% 12%
6% 7%
0.01 0.001
1.3
1.0
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2.4 2.8 2.0
1.5 1.9 1.1
0.01 0.035 0.01
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